Lobsters hold the secret of a long, cancer-free life in their genes
The American lobster — easily recognizable by its two hefty claws — can reach the impressive age of 100 years. The remarkable longevity is accompanied by very few signs of aging; it continuously grows and reproduces throughout its life and does not suffer from age-related diseases such as cancer. This exceptional resilience has garnered interest from researchers that are curious to decipher the reasons behind the lobster’s longevity and good health.

Could the genome of the American lobster provide clues about their healthy aging? Researchers at the Gloucester Marine Genomics Institute have recently published the first draft of the American lobster genome, which revealed surprising, first insights into the animal’s unique resilience mechanisms. Their work was published in the journal Science Advances.
The researchers found genes encoding for a novel class of proteins that combine both neuronal and immune-related functions. By coupling the neural and immune system, the lobster could fight off pathogens more efficiently.
The researchers also surveyed the lobster genome for genes involved in safeguarding the genome. These safeguards prevent genomic alterations and mutations, which is crucial for longevity and warding off cancer. The researchers found that the American lobster has an extended repertoire of genes encoding for proteins that silence certain regions of the genome. These regions need to be silenced to prevent potentially disease-causing mutations such as chromosomal rearrangements. By ensuring that these regions remain silenced, the American lobster safeguards its genome throughout its long life.
With the newly deciphered lobster genome as a starting point, future research will provide further insight into the healthy aging strategies of the American lobster. More than a mere delicacy, the humble lobster could teach us a lot about healthy aging.
This story originally appeared on Massive Science, an editorial partner site that publishes science stories by scientists. Subscribe to their newsletter to get even more science sent straight to you.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer’s code through functional connections
A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.